Morgan, George
Back, Emily
Besser, Martin
Hallett, Timothy B.
Guzauskas, Gregory F.
Funding for this research was provided by:
Bill and Melinda Gates Foundation
Prime HCD
Article History
Received: 1 December 2023
Accepted: 28 January 2024
First Online: 1 February 2024
Competing interests
: GM, EB, and GG are employees of Prime HCD, and received research support from Bill & Melinda Gates Foundation, to perform this study. MB Sponsorship for meetings: Novartis, Amgen, Grifols, GBT, Advisory boards: Hemeo, Forte, GBT, Agios, Novartis. MB & TH received renumeration for their expert input from Prime HCD for this study.